Bin Du

TL;DR: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.

TL;DR: The 2019-nCoV epidemic spreads rapidly by human-to-human transmission and the disease severity (including oxygen saturation, respiratory rate, blood leukocyte/lymphocyte count and chest X-ray/CT manifestations) predict poor clinical outcomes.

TL;DR: The findings suggest that CAZ-AVI treatment is effective and safe compared with other antibiotics, including colistin, in CRE BSI, and in patients infected with CRE producing Klebsiella pneumoniae carbapenemase, the 30-day mortality is significantly lower.

TL;DR: SARS-CoV-2neutralizing antibody JS016 did not show clinical efficacy among hospitalized Chinese patients with moderate to severe COVID-19 disease and further studies are needed to assess the efficacy of the neutralizing antibody to prevent disease deterioration and its benefits among groups of patients specified by disease course and severity.

TL;DR: Wang et al. as discussed by the authors analyzed the relationship between case volume and hospital mortality among patients with septic shock, the most severe complication of sepsis, using multivariate linear regression and restricted cubic splines.